Glycated Hemoglobin and Outcomes in Patients with Advanced Diabetic Chronic Kidney Disease
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Diabetes is the major risk factor for end-stage renal disease (ESRD) worldwide. In advanced chronic kidney disease (CKD), less is known about the predictive value of HbA1c. We enrolled 2401 diabetic patients with stage 3–4 and stage 5 CKD, who were classified into 4 groups according to their baseline HbA1c values (<6%, 6%–7%, 7%–9% and >9%). During the median follow-up of 3 years, 895 patients developed ESRD and 530 died. In linear regression analysis, higher HbA1c correlated with higher eGFR in patients with stage 5 CKD but not in stage 3–4 CKD. In Cox regression analysis, a trend toward worse clinical outcomes existed when the HbA1c level exceeded 6% in stage 3–4 CKD, but the significance was only observed for >9%. The hazard ratios (HRs) for ESRD, all-cause mortality and combined CV events with mortality in the group of HbA1c >9% were 1.6 (95% CI, 1.07 to 2.38), 1.52 (95% CI, 0.97 to 2.38) and 1.46 (95% CI, 1.02 to 2.09), respectively. This study demonstrates that the higher HbA1c level is associated higher risks for clinical outcomes in diabetic patients with stage 3–4 CKD but not in stage 5 CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Intensive glucose control (A1C levels <7% in T2D and <7.5% in T1D) in several clinical trials was found to reduce the risk of incident albuminuria (A2) and DKD onset.70,78,90,406–410”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [406]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,006
Ismail-Beigi, F., Craven, T., Banerji, M. A., Basile, J., Calles, J., Cohen, R. M., Cuddihy, R., Cushman, W. C., Genuth, S., Grimm, R. H., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60576-4 · Cited by 1,428
Ray, K. K., Seshasai, S. R. K., Wijesuriya, S., Sivakumaran, R., Nethercott, S., Preiss, D., Erqou, S., & Sattar, N. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60697-8 · Cited by 1,383
KDOQI clinical practice guideline for diabetes and CKD: 2012 update
(2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.07.005 · Cited by 1,320
Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
Currie, C. J., Peters, J. R., Tynan, A., Evans, M., Heine, R. J., Bracco, O. L., Zagar, T., & Poole, C. D. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61969-3 · Cited by 874
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes
The DCCT/EDIC Research Group (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1111732 · Cited by 568
Inaba, M., Okuno, S., Kumeda, Y., Yamada, S., Imanishi, Y., Tabata, T., Okamura, M., Okada, S., Yamakawa, T., Ishimura, E., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070772 · Cited by 493
Hypoglycemia, Diabetes, and Cardiovascular Events
Desouza, C. V., Bolli, G. B., & Fonseca, V. (2010) · Diabetes Care · doi:10.2337/dc09-2082 · Cited by 443
Frequency of hypoglycemia and its significance in chronic kidney disease
Moen, M. F., Zhan, M., Hsu, V. D., Walker, L. D., Einhorn, L. M., Seliger, S. L., & Fink, J. C. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00800209 · Cited by 423
Standards of Medical Care in Diabetes—2015: Summary of Revisions
(2015) · Diabetes Care · doi:10.2337/dc15-s003 · Cited by 382
Comparison of glycated albumin and hemoglobin A1c levels in diabetic subjects on hemodialysis
Peacock, T. P., Shihabi, Z. K., Bleyer, A. J., Dolbare, E. L., Byers, J. R., Knovich, M. A., Calles-Escandon, J., Russell, G. B., & Freedman, B. I. (2008) · Kidney International · doi:10.1038/ki.2008.25 · Cited by 323
Shurraw, S. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.537 · Cited by 269
Hemoglobin Carbamylation in Uremia
Flückiger, R., Harmon, W., Meier, W., Loo, S., & Gabbay, K. H. (1981) · New England Journal of Medicine · doi:10.1056/nejm198104023041406 · Cited by 262
A1C and Survival in Maintenance Hemodialysis Patients
Kalantar-Zadeh, K., Kopple, J. D., Regidor, D. L., Jing, J., Shinaberger, C. S., Aronovitz, J., McAllister, C. J., Whellan, D., & Sharma, K. (2007) · Diabetes Care · doi:10.2337/dc06-2127 · Cited by 254
de Boer, I. H., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2113 · Cited by 254
Hsu, C.-C., Hwang, S.-J., Wen, C.-P., Chang, H.-Y., Chen, T., Shiu, R.-S., Horng, S.-S., Chang, Y.-K., & Yang, W.-C. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.07.018 · Cited by 207
Self-citationImpact of Glycemic Control on Survival of Diabetic Patients on Chronic Regular Hemodialysis
Oomichi, T., Emoto, M., Tabata, T., Morioka, T., Tsujimoto, Y., Tahara, H., Shoji, T., & Nishizawa, Y. (2006) · Diabetes Care · doi:10.2337/dc05-1887 · Cited by 191
Red blood cell survival in chronic renal failure
Ly, J., Marticorena, R., & Donnelly, S. (2004) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(04)00951-5 · Cited by 159
Hwang, S., Yang, W.-C., Lin, M., Mau, L.-W., Chen, H.-C., & Taiwan Society of Nephrology (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq308 · Cited by 149
Self-citationAssociation of Hyperuricemia with Renal Outcomes, Cardiovascular Disease, and Mortality
Liu, W., Hung, C., Chen, S., Yeh, S.-M., Lin, M., Chiu, Y., Kuo, M., Chang, J., Hwang, S., & Chen, H. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09420911 · Cited by 142
Self-citationImpact of End‐Stage Renal Disease and Dialysis on Glycemic Control
MAK, R. H. K. (2000) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2000.00007.x · Cited by 106
Relationship between assays of glycemia in diabetic subjects with advanced chronic kidney disease
Freedman, B. I., Shihabi, Z. K., Andries, L., Cardona, C. Y., Peacock, T. P., Byers, J. R., Russell, G. B., Stratta, R. J., & Bleyer, A. J. (2010) · American Journal of Nephrology · doi:10.1159/000287561 · Cited by 90
Yokoyama, H., Kanno, S., Takahashi, S., Yamada, D., Itoh, H., Saito, K., Sone, H., & Haneda, M. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06511208 · Cited by 77
Vos, F. E., Schollum, J. B., & Walker, R. (2011) · Clinical Kidney Journal · doi:10.1093/ndtplus/sfr140 · Cited by 61
Uzu, T., Hatta, T., Deji, N., Izumiya, T., Ueda, H., Miyazawa, I., Kanasaki, M., Isshiki, K., Nishio, T., & Arimura, T. (2009) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2009.00661.x · Cited by 53
Lee, C.-L., Li, T., Lin, S., Wang, J., Lee, I., Tseng, L., Song, Y.-M., Tsai, S., & Sheu, W. H. (2013) · American Journal of Nephrology · doi:10.1159/000351803 · Cited by 30
Agarwal, R., & Light, R. P. (2011) · American Journal of Nephrology · doi:10.1159/000328737 · Cited by 25
Glycated haemoglobin and the incidence of end-stage renal disease in diabetics
Oh, S. W., Kim, Y. C., Koo, H., Jin, D. C., Na, K. Y., Chae, D., Kim, S., & Chin, H. J. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq707 · Cited by 18
Cordeiro, A. C., Carrero, J. J., Barany, P. F., Qureshi, A. R., Heimbürger, O., Lindholm, B., & Stenvinkel, P. (2010) · American Journal of Nephrology · doi:10.1159/000322608 · Cited by 6
Coca, S. G., Ismail-Beigi, F., Haq, N., Krumholz, H. M., & Parikh, C. R. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.2230 · Cited by 1
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Chakraborty, W., Grisafe, B., Ye, H., Lightcap, I. V., Ni, K., & Datta, S. (2020) · Symposium on VLSI Technology · doi:10.1109/vlsitechnology18217.2020.9265064 · Cited by 63
Lim, L., Tsai, N., Lin, M., Hwang, D., Lin, H. Y., Lee, J., Hwang, S., Hung, C., & Chen, H. (2016) · Scientific Reports · doi:10.1038/srep36817 · Cited by 53
Self-citationÇöpür, S., Onal, E. M., Afşar, B., Ortíz, A., van Raalte, D. H., Cherney, D. Z. I., Rossing, P. R., & Kanbay, M. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107707 · Cited by 60
Nazzal, Z. A. S., Hamdan, Z. I., Masri, D., Abu-Kaf, O., & Hamad, M. (2020) · BMC Nephrology · doi:10.1186/s12882-020-02138-4 · Cited by 63
Metadata
- Authors
- Kuo, I.-C., Lin, H. Y.-H., Niu, S.-W., Hwang, D.-Y., Lee, J.-J., Tsai, J.-C., Hung, C.-C., Hwang, S.-J., & Chen, H.-C.
- Affiliations
- Kaohsiung Medical University (TW)
- Corresponding author
- Hung, Chi-Chih
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-01-28
- Volume
- 6
- Issue
- 1
- Pages
- 20028-20028
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4730215
- OpenAlex
- W2419005569
- Cited by
- 70
- References
- 40
- Citations by year
- 2026: 1 · 2025: 11 · 2024: 8 · 2023: 10 · 2022: 8 · 2021: 8 · 2020: 10 · 2019: 4 · 2018: 5 · 2017: 2 · 2016: 3
- FWCI
- 4.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HbA1c, diabetic nephropathy, end-stage renal disease, all-cause mortality, cardiovascular events, estimated glomerular filtration rate, glycemic control
- MeSH terms
- Aged, Cause of Death, Diabetic Nephropathies, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Kidney Failure, Chronic, Male, Middle Aged, Prognosis, Severity of Illness Index, Biomarkers, Comorbidity, Proportional Hazards Models, Patient Outcome Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

